OC-0102 DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts
Autor: | Offersen, B., Alsner, J., Nielsen, H.M., Bechmann, T., Nielsen, M.H., Mjaaland, I., Kamby, C., Krkove, C., Lorincz, T., Al-Rawi, S., Stoere, E.B., Schreiber, A., Krause, M., Kasti, U., Matthiessen, L.W., Kedzierawski, P., Marinko, T., Luukkaa, M., Skyttä, T., Jensen, M., Overgaard, J. |
---|---|
Zdroj: | In Radiotherapy and Oncology May 2022 170 Supplement 1:S76-S77 |
Databáze: | ScienceDirect |
Externí odkaz: |